Evan Raff, MD
Associate Professor of Medicine
Physician Leader for MDH Direct Care Service
Physician Chair, Adult Rapid Response Committee
Areas of Interest
Quality improvement, patient safety, clinical education, point-of-care ultrasound, and hepatology
About
Research/ Clinical Interests
Dr. Raff’s clinical and quality improvement interests are closely linked. His particular focus is on providing quality healthcare in an efficient manner and utilizing operational and system changes to accomplish these goals. He graduated from the University of Alabama at Birmingham Quality and Safety Academy in 2015. His previous quality improvement work focused on reducing central line-associated bloodstream infections, analyzing factors that contribute to hospital re-admissions, and improving the efficiency of inpatient medical rounds. Through grant-funded initiatives, his most recent efforts have been to improve teamwork and communication during rapid response events, reduce health inequities in the rapid response system for non-English speaking hospitalized patients, and optimize/integrate an early warning system into the workflow of the rapid response system to improve patient outcomes.
Bibliography
Raff LA, Reid TD, Johnson D, Raff EJ, Schneider AB, Charles AG, Gallaher JR. “Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS.” Am J Surg. 2022 Feb;223(2):388-394. Apr 20:S0002-9610(21)00233-6. doi: 10.1016/j.amjsurg.2021.04.004. Epub 2021 Apr 20. PMID: 33894980.
Raff L, Gallaher J, Johnson D, Raff E, Charles A, Reid T. “Time to Cannulation after ICU Admission Increases Mortality for Patents Requiring Veno-Venous ECMO for COVID-19 Associated Acute Respiratory Distress Syndrome.” Annals of Surgery. 2020 Dec 22. doi: 10.1097/SLA.0000000000004683. Epub ahead of print. PMID: 33630477.
Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Alcoholic Liver Disease Presents at Advanced Stage and Progresses Faster Compared to Non-alcoholic Fatty Liver Disease. Ann Hepatol. 2016 Mar-Apr;15(2):183-9.
Ravi S, Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease. Dig Dis Sci. 2015 Dec;60(12):3788-93.
Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Ulrich S, Daly A, Day CP, Kuo YF, Singal AK. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease. Am J Gastroenterol. 2015 Jun;110(6):846-56.
Raff E, Kakati D, Bloomer J, Shoreibah M, Rasheed K, Singal A. Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases. J Clin and Transl Hepatol. 2015 Mar;3(1):9-16.
Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K, Singal AK. Alcoholic Liver Disease Presents at Advanced Stage and Progresses Faster Compared to Non-alcoholic Fatty Liver Disease. Ann Hepatol. 2016 Mar-Apr;15(2):183-9.
Raff E, Singal A. Optimal Management of Alcoholic Hepatitis. Minerva Gastroenterologica E Dietologica 2014 March;60(1):25-38.